N@N

Finkelstein Thompson LLP Announces Investigation of TomoTherapy Incorporated

_{//health-fitness.news-articles.net/content/2011/ .. s-investigation-of-tomotherapy-incorporated.html}
^{Published in Health and Fitness on Monday, March 7th 2011 at 16:45 GMT by Market Wire}  

WASHINGTON--([ BUSINESS WIRE ])--Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of TomoTherapy Incorporated (aTomoTherapya or the aCompanya) (Nasdaq: TOMO) concerning the proposed acquisition of the Company by Accuray Incorporated. Under the terms of the offer, TomoTherapy shareholders will receive $4.80 in cash and stock for each share of TomoTherapy common stock held in a transaction valued at approximately $277million.

The investigation is focused on the potential unfairness of the consideration to TomoTherapy shareholders, the process by which the Board of Directors considered the transaction, and potential conflicts of interests among TomoTherapy Board members. In particular, according to Yahoo! Finance, at least one analyst has set a target price of $5.00 for TomoTherapy shares.

If you are interested in discussing your rights as a TomoTherapy shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at [ contact@finkelsteinthompson.com ].

Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.

To learn more about Finkelstein Thompson LLP, please visit our web site at [ www.finkelsteinthompson.com ]. Attorney advertising. Prior results do not guarantee similar outcomes.